Literature DB >> 29268122

Resveratrol and pinostilbene confer neuroprotection against aging-related deficits through an ERK1/2-dependent mechanism.

Erika N Allen1, Sneha Potdar2, Victor Tapias3, Mayur Parmar4, Cassia S Mizuno5, Agnes Rimando5, Jane E Cavanaugh6.   

Abstract

Age-related declines in motor function may be due, in part, to an increase in oxidative stress in the aging brain leading to dopamine (DA) neuronal cell death. In this study, we examined the neuroprotective effects of natural antioxidants resveratrol and pinostilbene against age-related DAergic cell death and motor dysfunction using SH-SY5Y neuroblastoma cells and young, middle-aged, and old male C57BL/6 mice. Resveratrol and pinostilbene protected SH-SY5Y cells from a DA-induced decrease in cell viability. Dietary supplementation with resveratrol and pinostilbene inhibited the decline of motor function observed with age. While DA and its metabolites (DOPAC and HVA), dopamine transporter, and tyrosine hydroxylase levels remain unchanged during aging or treatment, resveratrol and pinostilbene increased ERK1/2 activation in vitro and in vivo in an age-dependent manner. Inhibition of ERK1/2 in SH-SY5Y cells decreased the protective effects of both compounds. These data suggest that resveratrol and pinostilbene alleviate age-related motor decline via the promotion of DA neuronal survival and activation of the ERK1/2 pathways.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; ERK1/2; Pinostilbene; Resveratrol; SH-SY5Y; Striatum; Substantia nigra

Mesh:

Substances:

Year:  2017        PMID: 29268122      PMCID: PMC5866762          DOI: 10.1016/j.jnutbio.2017.10.015

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  78 in total

1.  Risk of hip fracture in women: not only a smoking issue.

Authors:  Graziano Onder; Claudio Pedone; Giovanni Gambassi
Journal:  Arch Intern Med       Date:  2002-01-14

2.  Absorption of trans-resveratrol in rats.

Authors:  G J Soleas; M Angelini; L Grass; E P Diamandis; D M Goldberg
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

Review 3.  Role of free radicals in aging and disease.

Authors:  D Harman
Journal:  Ann N Y Acad Sci       Date:  1992-12-26       Impact factor: 5.691

Review 4.  Oxidants, antioxidants, and the degenerative diseases of aging.

Authors:  B N Ames; M K Shigenaga; T M Hagen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

5.  Change in physical performance over time in older women: the Women's Health and Aging Study.

Authors:  Graziano Onder; Brenda W J H Penninx; Pablo Lapuerta; Linda P Fried; Glenn V Ostir; Jack M Guralnik; Marco Pahor
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-05       Impact factor: 6.053

6.  Loss of motor coordination in an aging mouse model.

Authors:  Erika N Allen; Jane E Cavanaugh
Journal:  Behav Brain Res       Date:  2014-03-25       Impact factor: 3.332

7.  Resveratrol reduces glutamate-mediated monocyte chemotactic protein-1 expression via inhibition of extracellular signal-regulated kinase 1/2 pathway in rat hippocampal slice cultures.

Authors:  Eun Ok Lee; Hee Ju Park; Jihee Lee Kang; Hye-Sun Kim; Young Hae Chong
Journal:  J Neurochem       Date:  2009-12-28       Impact factor: 5.372

8.  Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.

Authors:  Jianfei Chao; Man-Shan Yu; Yuen-Shan Ho; Mingfu Wang; Raymond Chuen-Chung Chang
Journal:  Free Radic Biol Med       Date:  2008-07-16       Impact factor: 7.376

9.  Diffuse Lewy body disease presenting with a supranuclear gaze palsy.

Authors:  J M Fearnley; T Revesz; D J Brooks; R S Frackowiak; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

10.  Caloric restriction or resveratrol supplementation and ageing in a non-human primate: first-year outcome of the RESTRIKAL study in Microcebus murinus.

Authors:  Alexandre Dal-Pan; Jérémy Terrien; Fabien Pifferi; Roger Botalla; Isabelle Hardy; Julia Marchal; Alexandre Zahariev; Isabelle Chery; Philippe Zizzari; Martine Perret; Jean Luc Picq; Jacques Epelbaum; Stéphane Blanc; Fabienne Aujard
Journal:  Age (Dordr)       Date:  2010-06-09
View more
  5 in total

1.  Lipopolysaccharide Induces Gliotoxicity in Hippocampal Astrocytes from Aged Rats: Insights About the Glioprotective Roles of Resveratrol.

Authors:  Larissa Daniele Bobermin; Rômulo Rodrigo de Souza Almeida; Fernanda Becker Weber; Lara Scopel Medeiros; Lívia Medeiros; Angela T S Wyse; Carlos-Alberto Gonçalves; André Quincozes-Santos
Journal:  Mol Neurobiol       Date:  2022-01-07       Impact factor: 5.590

2.  The Invasive Species Reynoutria japonica Houtt. as a Promising Natural Agent for Cardiovascular and Digestive System Illness.

Authors:  Shaoyang Liu; Ruiyuan Zhang; Xing Zhang; Shun Zhu; Siyu Liu; Jue Yang; Zhiping Li; Tianhui Gao; Fang Liu; Huiling Hu
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

3.  Evolvement of nutraceutical onion plants engineered for resveratrol biosynthetic pathway.

Authors:  Raju Naini; P Pavankumar; S Prabhakar; Rama Krishna Kancha; Khareedu Venkateswara Rao; Vudem Dashavantha Reddy
Journal:  Plant Cell Rep       Date:  2019-06-01       Impact factor: 4.570

4.  Metformin attenuates the D‑galactose‑induced aging process via the UPR through the AMPK/ERK1/2 signaling pathways.

Authors:  Hua Cai; Baoai Han; Yujuan Hu; Xueyan Zhao; Zuhong He; Xubo Chen; Haiying Sun; Jie Yuan; Yongqin Li; Xiuping Yang; Wen Kong; Wei-Jia Kong
Journal:  Int J Mol Med       Date:  2020-01-08       Impact factor: 4.101

Review 5.  Effects and Mechanisms of Resveratrol on Aging and Age-Related Diseases.

Authors:  Dan-Dan Zhou; Min Luo; Si-Yu Huang; Adila Saimaiti; Ao Shang; Ren-You Gan; Hua-Bin Li
Journal:  Oxid Med Cell Longev       Date:  2021-07-11       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.